Regeneron Pharmaceuticals

Organization

American biotechnology company that was outbid by TTAM in the 23andMe bankruptcy auction

2 stories

California Attorney General Sues 23andMe Successor Over 2023 Genetic Data Breach

Gene Therapy for Inherited Deafness Shows Sustained Hearing Improvement Over 2.5-Year Follow-Up